# To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity

> **NCT03795701** · NA · COMPLETED · sponsor: **Texas Tech University** · enrollment: 73 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Saxenda®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03795701
- **Lead sponsor:** Texas Tech University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-08
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2023-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03795701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03795701, "To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03795701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*